Provenienza dei contatti di primo grado di Ken Takeshita
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Ken Takeshita tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
CAREFUSION CORPORATION | Medical Distributors | Corporate Officer/Principal | |
Mallinckrodt Medical, Inc.
Mallinckrodt Medical, Inc. Medical SpecialtiesHealth Technology Mallinckrodt Medical, Inc. manufactures and markets healthcare products. Its products include contrast media & delivery systems, radiology imaging products, radiopharmaceuticals and urology imaging systems. The company is headquartered in Pointe-Claire, Canada. | Medical Specialties | Corporate Officer/Principal | |
The University of Chicago | College/University | Doctorate Degree | |
Loyola Marymount University | College/University | Masters Business Admin | |
Roanoke College | College/University | Undergraduate Degree | |
St. John's University | College/University | Undergraduate Degree | |
University of Delaware | College/University | Director/Board Member | |
Virginia Polytechnic Institute & State University | College/University | Masters Business Admin | |
DAIICHI SANKYO CO., LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Biotechnology | President | |
American Regent, Inc.
American Regent, Inc. Pharmaceuticals: MajorHealth Technology American Regent, Inc. manufactures and distributes pharmaceutical products. It offers generic and branded injectables as well as intravenous iron therapies. The company was founded in 1967 and is headquartered in Shirley, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
Technology Alliance
Technology Alliance Miscellaneous Commercial ServicesCommercial Services Technology Alliance supports and promotes technology-based businesses and research institutions. It organizes programs, events, data analysis, and policy activities for education, research, and entrepreneurship technology advancement. The company was founded by William H. Gates Sr. in 1996 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member | |
Washington Biotechnology & Biomedical Association | Chairman | ||
Arzeda Corp.
Arzeda Corp. BiotechnologyHealth Technology Arzeda Corp. operates as a synthetic biology company. It works thru agriculture, functionalized sweeteners and ingredients, chemicals and materials, and pharmaceuticals and diagnostics. The company was founded by Eric Althoff, David Baker, Daniela Grabs-R?thlisberger, Michael A. Martino and Alexandre Zanghellini in 2008 and is headquartered in Seattle, WA. | Biotechnology | Founder | |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
AMPIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Excision BioTherapeutics, Inc.
Excision BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Excision BioTherapeutics, Inc. develops gene editing therapeutics for the treatment of life-threatening disease caused by viral infections. The firm focuses on Human Immunodeficiency Virus -1 therapeutics, JC Virus and Progressive Multifocal Leukoencephalopathy, Hepatitis B virus therapeutics, and CRISPR vaccinations?. The company was founded by David Rowe, Kamel Khalili, Thomas Malcolm, and Rob Simmons in 2015 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Healios N.A., Inc. | Director/Board Member | ||
HemaFlo Therapeutics, Inc.
HemaFlo Therapeutics, Inc. BiotechnologyHealth Technology HemaFlo Therapeutics, Inc. is an American private company that develops drag-reducing polymers (DRP) to improve blood flow in acute and chronic conditions associated with decreased tissue perfusion. DRPs are administered intravenously and work mechanically to reduce friction in flowing blood and stimulate blood vessel dilation, resulting in improved blood flow without increasing blood pressure. The CEO of the company is Michael A. Martino. | Biotechnology | Chief Executive Officer | |
CaraVan Biologix | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 26 |
Regno Unito | 2 |
Canada | 2 |
Giappone | 2 |
Settori
Health Technology | 16 |
Consumer Services | 7 |
Commercial Services | 4 |
Distribution Services | 2 |
Posizioni
Director/Board Member | 17 |
Chief Executive Officer | 6 |
Corporate Officer/Principal | 6 |
President | 6 |
Chairman | 3 |
Contatti più connessi
Insiders | |
---|---|
Michael Martino | 14 |
Glenn Gormley | 12 |
Kenneth Joseph Keller | 6 |
Richard van Duyne | 1 |
- Borsa valori
- Insiders
- Ken Takeshita
- Connessioni Società